Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas

BACKGROUND: Borderline resectable pancreatic cancers infiltrate into adjacent vascular structures to an extent that makes an R0 resection unlikely when pancreatectomy is performed de novo. In a pilot study, Alliance for Clinical Trials in Oncology Trial A021101, the median survival of patients who r...

Descripción completa

Detalles Bibliográficos
Autores principales: Katz, Matthew H. G., Ou, Fang-Shu, Herman, Joseph M., Ahmad, Syed A., Wolpin, Brian, Marsh, Robert, Behr, Spencer, Shi, Qian, Chuong, Michael, Schwartz, Lawrence H., Frankel, Wendy, Collisson, Eric, Koay, Eugene J., Hubbard, JoLeen M., Leenstra, James L., Meyerhardt, Jeffrey, O’Reilly, Eileen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530569/
https://www.ncbi.nlm.nih.gov/pubmed/28750659
http://dx.doi.org/10.1186/s12885-017-3441-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530569/
https://www.ncbi.nlm.nih.gov/pubmed/28750659
http://dx.doi.org/10.1186/s12885-017-3441-z

Ejemplares similares